State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
Beijing Key Laboratory of Drug Target Identification and New Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100006, China.
Int J Mol Sci. 2022 Oct 21;23(20):12694. doi: 10.3390/ijms232012694.
Kaempferol, a natural plant flavonoid compound, has a neuroprotective effect on ischemic stroke, while the specific mechanism remains unclear. In the current study, we applied the comprehensive strategy that combines network pharmacology and experimental evaluation to explore the potential mechanism of kaempferol in the treatment of cerebral ischemia. First, network pharmacology analysis identified the biological process of kaempferol, suggesting that kaempferol may partly help in treating ischemic stroke by regulating apoptosis and inflammatory response. Then, we evaluated the efficacy of kaempferol in the acute stage of ischemic stroke and elucidated its effects and possible mechanisms on cell apoptosis and neuroinflammation involved by neutrophils. The results showed that kaempferol could significantly reduce the modified neurological severity score (mNSS), and reduce the volume of cerebral infarction and the degree of cerebral edema. In terms of anti-apoptosis, kaempferol could significantly reduce the number of TUNEL-positive cells, inhibit the expression of pro-apoptotic proteins and promote the expression of anti-apoptotic proteins. Kaempferol may play an anti-apoptotic role by up-regulating the expression level of the BDNF-TrkB-PI3K/AKT signaling pathway. In addition, we found that kaempferol inhibited neuron loss and the activation of glial cells, as well as the expression level of the inflammatory protein COX-2 and the classic pro-inflammatory signaling pathway TLR4/MyD88/NF-κB in the ischemic brain, reduced MPO activity and neutrophil counts in peripheral blood, and down-regulated neutrophil aggregation and infiltration in the ischemic brain. Western blot revealed that kaempferol down-regulated the activation of the JAK1/STAT3 signaling pathway in neutrophils and ischemic brains. Our study showed that kaempferol inhibited the activation and number of neutrophils in the rat peripheral blood and brain, which may be related to the down-regulation of the JAK1/STAT3 pathway.
山柰酚是一种天然植物类黄酮化合物,对缺血性中风具有神经保护作用,但其具体机制尚不清楚。在本研究中,我们应用网络药理学和实验评价相结合的综合策略,探讨山柰酚治疗脑缺血的潜在机制。首先,网络药理学分析鉴定出山柰酚的生物学过程,提示山柰酚可能通过调节细胞凋亡和炎症反应部分有助于治疗缺血性中风。然后,我们评估了山柰酚在缺血性中风急性期的疗效,并阐明了其对中性粒细胞参与的细胞凋亡和神经炎症的作用及其可能机制。结果表明,山柰酚能显著降低改良神经功能缺损评分(mNSS),减少脑梗死体积和脑水肿程度。在抗细胞凋亡方面,山柰酚能显著减少 TUNEL 阳性细胞数,抑制促凋亡蛋白的表达,促进抗凋亡蛋白的表达。山柰酚可能通过上调 BDNF-TrkB-PI3K/AKT 信号通路的表达水平发挥抗凋亡作用。此外,我们发现山柰酚抑制神经元丢失和胶质细胞激活,以及缺血性大脑中 COX-2 炎性蛋白和经典促炎信号通路 TLR4/MyD88/NF-κB 的表达水平,降低外周血中 MPO 活性和中性粒细胞计数,并下调缺血性大脑中中性粒细胞的聚集和浸润。Western blot 显示山柰酚下调中性粒细胞和缺血性大脑中 JAK1/STAT3 信号通路的激活。本研究表明,山柰酚抑制了大鼠外周血和大脑中性粒细胞的激活和数量增加,这可能与 JAK1/STAT3 通路的下调有关。